Focusing on CD209-expressing CD14 monocytes, it was demonstrated that they are enriched within an inflamed microenvironment where they participate in MS disease activity by supporting CD4 T-cell activation (9) and in rheumatoid arthritis and psoriatic arthritis patients through secretion of pro-inflammatory cytokines (54). This evidence concerns the gene CD209 and rheumatoid arthritis.